Cargando…
Preclinical and Clinical Immunotherapeutic Strategies in Epithelial Ovarian Cancer
In the past 20 years, the immune system has increasingly been recognized as a major player in tumor cell control, leading to considerable advances in cancer treatment. While promising with regards to melanoma, renal cancer and non-small cell lung cancer, immunotherapy provides, for the time being, l...
Autores principales: | Martinez, Alejandra, Delord, Jean-Pierre, Ayyoub, Maha, Devaud, Christel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409311/ https://www.ncbi.nlm.nih.gov/pubmed/32630708 http://dx.doi.org/10.3390/cancers12071761 |
Ejemplares similares
-
Immunotherapeutic Strategies for Gastric Carcinoma: A Review of Preclinical and Clinical Recent Development
por: Abozeid, Mohamed, et al.
Publicado: (2017) -
Immunotherapeutic Approaches in Ovarian Cancer
por: Yoon, Hyunho, et al.
Publicado: (2023) -
Immunotherapeutic approaches to ovarian cancer treatment
por: Chester, Cariad, et al.
Publicado: (2015) -
Phased differentiation of γδ T and T CD8 tumor-infiltrating lymphocytes revealed by single-cell transcriptomics of human cancers
por: Cerapio, Juan-Pablo, et al.
Publicado: (2021) -
Circulating Exhausted PD-1(+)CD39(+) Helper CD4 T Cells Are Tumor-Antigen-Specific and Predict Response to PD-1/PD-L1 Axis Blockade
por: Martinez-Gomez, Carlos, et al.
Publicado: (2022)